Hikma adds generics sales, marketing EVP
Hikma Pharmaceuticals has tapped Kristy Ronco to serve as executive vice president of sales and marketing for its generics division.
Ronco will lead the company’s generics retail sales, addiction therapy sales and branded sales teams.
“Kristy is a talented leader with significant pharmaceutical industry experience across sales, marketing, operations, market analysis, contracts and pricing, and we are delighted she is joining our team,” Hikma’s generics division president Brian Hoffmann said in a press statement. “I am looking forward to working closely with Kristy and her team to deliver substantial value to our customers, employees and the broader communities we serve.”
Ronco joins Hikma after an 11-year stint at Zydus Pharmaceuticals, where she was most recently senior vice president of sales and marketing. She has also held successive positions of increasing responsibility in marketing, contracts, pricing and market analysis at Teva, Sandoz, Aventis and Johnson & Johnson. She also is a registered nurse with extensive clinical patient-care experience across a range of medical disciplines and specialties.
“I am thrilled to be joining Hikma’s generics business and look forward to helping the company fulfill its vital mission of producing and distributing high-quality generic medicines that each day put better health within reach of millions of people,” Ronco said, in a press statement.
No comments found